Authors:
Grady, KL
Meyer, P
Mattea, A
White-Williams, C
Ormaza, S
Kaan, A
Todd, B
Chillcott, S
Dressler, D
Fu, A
Piccione, W
Costanzo, MR
Citation: Kl. Grady et al., Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation, J HEART LUN, 20(6), 2001, pp. 657-669
Authors:
Lee, JW
Petersen, ME
Lin, P
Dressler, D
Bekersky, I
Citation: Jw. Lee et al., Quantitation of free and total amphotericin B in human biologic matrices by a liquid chromatography tandem mass spectrometric method, THER DRUG M, 23(3), 2001, pp. 268-276
Authors:
Bekersky, I
Dressler, D
Alak, A
Boswell, G
Mekki, QA
Citation: I. Bekersky et al., Comparative tacrolimus pharmacokinetics: Normal versus mildly hepatically impaired subjects, J CLIN PHAR, 41(6), 2001, pp. 628-635
Citation: I. Bekersky et al., Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose, J CLIN PHAR, 41(3), 2001, pp. 289-297
Citation: I. Bekersky et al., Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects, J CLIN PHAR, 41(2), 2001, pp. 176-182
Citation: D. Dressler et G. Dirnberger, Botulinum toxin antibody testing: Comparison between the immunoprecipitation assay and the mouse diaphragm assay, EUR NEUROL, 45(4), 2001, pp. 257-260
Citation: D. Dressler et al., Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome, EUR NEUROL, 45(4), 2001, pp. 287-288
Authors:
Mancinelli, LM
Frassetto, L
Floren, LC
Dressler, D
Carrier, S
Bekersky, I
Benet, LZ
Christians, U
Citation: Lm. Mancinelli et al., The pharmacokinetics and metabolic disposition of tacrolimus: A comparisonacross ethnic groups, CLIN PHARM, 69(1), 2001, pp. 24-31
Authors:
Munchau, A
Palmer, JD
Dressler, D
O'Sullivan, JD
Tsang, KL
Jahanshahi, M
Quinn, NP
Lees, AJ
Bhatia, KP
Citation: A. Munchau et al., Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia, BRAIN, 124, 2001, pp. 769-783
Authors:
Munchau, A
Corna, S
Gresty, MA
Bhatia, KP
Palmer, JD
Dressler, D
Quinn, NP
Rothwell, JC
Bronstein, AM
Citation: A. Munchau et al., Abnormal interaction between vestibular and voluntary head control in patients with spasmodic torticollis, BRAIN, 124, 2001, pp. 47-59
Authors:
Dressler, D
Zettl, U
Benecke, R
Bigalke, H
Citation: D. Dressler et al., Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure?, MOVEMENT D, 15(6), 2000, pp. 1279-1281
Authors:
Dressler, D
Dirnberger, G
Bhatia, KP
Irmler, A
Quinn, NP
Bigalke, H
Marsden, CD
Citation: D. Dressler et al., Botulinum toxin antibody testing: Comparison between the mouse protection assay and the mouse lethality assay, MOVEMENT D, 15(5), 2000, pp. 973-976
Citation: D. Dressler et al., The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humans, J NEUROL, 247(8), 2000, pp. 630-632
Citation: D. Dressler et Jc. Rothwell, Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle, EUR NEUROL, 43(1), 2000, pp. 13-16
Authors:
Dressler, D
Wright, JR
Houghton, JB
Kalra, PA
Citation: D. Dressler et al., Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy, NEPH DIAL T, 14(8), 1999, pp. 2049-2050
Citation: I. Bekersky et al., Dose linearity after oral administration of tacrolimus 1-mg capsules at doses of 3, 7, and 10 mg, CLIN THER, 21(12), 1999, pp. 2058-2064
Authors:
Bekersky, I
Dressler, D
Colburn, W
Mekki, Q
Citation: I. Bekersky et al., Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design, J CLIN PHAR, 39(10), 1999, pp. 1032-1037